Holen Sie sich die Stockscreener-App
1.32
5.04%
-0.07
Vorhandelsmarkt:
1.38
0.06
+4.55%
Schlusskurs vom Vortag:
$1.39
Offen:
$1.4
24-Stunden-Volumen:
277.88K
Relative Volume:
0.22
Marktkapitalisierung:
$34.34M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-1.40M
KGV:
-6.3645
EPS:
-0.2074
Netto-Cashflow:
$-10.49M
1W Leistung:
+3.13%
1M Leistung:
-23.70%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$1.31
$1.40
1-Wochen-Bereich:
$1.26
$1.70
52-Wochen-Spanne:
$1.11
$33.66
Liminatus Pharma Inc Stock (LIMN) Company Profile
Firmenname
Liminatus Pharma Inc
Sektor
Branche
Telefon
213-273-5453
Adresse
6 CENTERPOINTE DR., LA PALMA
Vergleichen Sie LIMN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LIMN
Liminatus Pharma Inc
|
1.32 | 37.62M | 0 | -1.40M | -10.49M | -0.2074 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Liminatus Pharma Inc Aktie (LIMN) Neueste Nachrichten
Is Liminatus Pharma Inc. stock entering bullish territoryQuarterly Performance Summary & Community Verified Watchlist Alerts - newser.com
What technical models suggest about Liminatus Pharma Inc.’s comebackGlobal Markets & Stepwise Trade Execution Plans - newser.com
Analyzing recovery setups for Liminatus Pharma Inc. Equity Warrant investors2025 Market Sentiment & Safe Entry Zone Tips - newser.com
Is Liminatus Pharma Inc. stock recession proofTrade Signal Summary & Free Accurate Trade Setup Notifications - newser.com
Backtesting results for Liminatus Pharma Inc. trading strategiesJuly 2025 Pullbacks & Weekly Market Pulse Updates - newser.com
How strong is Liminatus Pharma Inc. stock revenue growthEarnings Overview Summary & Momentum Based Trading Signals - newser.com
Tools to assess Liminatus Pharma Inc. Equity Warrant’s risk profileQuarterly Growth Report & Capital Efficient Trading Techniques - newser.com
Technical analysis overview for Liminatus Pharma Inc. Equity Warrant stockJuly 2025 Summary & Risk Managed Investment Signals - newser.com
Analyzing Liminatus Pharma Inc. Equity Warrant with multi timeframe charts2025 Performance Recap & Community Verified Watchlist Alerts - newser.com
Using data models to predict Liminatus Pharma Inc. Equity Warrant stock movementJuly 2025 Price Swings & AI Based Buy and Sell Signals - newser.com
Long term hold vs stop loss in Liminatus Pharma Inc.Weekly Trading Summary & AI Forecast Swing Trade Picks - newser.com
Can Liminatus Pharma Inc. stock deliver consistent earnings growthJuly 2025 Fed Impact & High Yield Equity Trading Tips - newser.com
What momentum shifts mean for Liminatus Pharma Inc. Equity WarrantEarnings Recap Summary & High Return Stock Watch Alerts - newser.com
How Liminatus Pharma Inc. stock benefits from strong dollar2025 Key Highlights & Technical Pattern Based Signals - newser.com
Pattern recognition hints at Liminatus Pharma Inc. Equity Warrant upsideJuly 2025 PostEarnings & Safe Entry Zone Tips - newser.com
What risks investors should watch in Liminatus Pharma Inc. Equity Warrant stockJuly 2025 Levels & Weekly Return Optimization Alerts - newser.com
Will Liminatus Pharma Inc. Equity Warrant stock split attract more investorsJuly 2025 Highlights & Safe Swing Trade Setup Alerts - newser.com
Why Liminatus Pharma Inc. Equity Warrant stock is seen as undervaluedMarket Activity Summary & Daily Profit Maximizing Trade Tips - newser.com
Can Liminatus Pharma Inc. Equity Warrant stock double in next 5 yearsMarket Movers & Safe Entry Point Alerts - newser.com
Multi factor analysis applied to Liminatus Pharma Inc.Weekly Gains Report & Risk Adjusted Buy/Sell Alerts - newser.com
Is Liminatus Pharma Inc. Equity Warrant stock a good choice for value investorsTrade Entry Report & Accurate Technical Buy Alerts - newser.com
Analyzing drawdowns of Liminatus Pharma Inc. Equity Warrant with statistical toolsJuly 2025 PreEarnings & Precise Swing Trade Entry Alerts - newser.com
How Liminatus Pharma Inc. stock reacts to Fed rate cutsGap Down & Daily Profit Maximizing Tips - newser.com
What analysts say about Liminatus Pharma Inc Equity Warrant stockRetail Investor Activity & Grow Smarter With Pro-Level Research - earlytimes.in
Is Liminatus Pharma Inc. Equity Warrant stock supported by strong cash flowsJuly 2025 Breakouts & Weekly High Potential Stock Alerts - newser.com
How to use Fibonacci retracement on Liminatus Pharma Inc. Equity WarrantEarnings Summary Report & Fast Moving Trade Plans - newser.com
Will Liminatus Pharma Inc. Equity Warrant stock deliver strong dividend growthPortfolio Gains Summary & Growth Focused Entry Point Reports - newser.com
Finanzdaten der Liminatus Pharma Inc-Aktie (LIMN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):